UNICANCER

UNICANCER, based in Paris, is the network of France's comprehensive cancer centres and its academic trials sponsor, federating eighteen centres including Gustave Roussy, Institut Curie, the Institut du Cancer de Montpellier and Centre Jean Perrin. It runs the UCBG breast group, the PRODIGE gastrointestinal group whose PRODIGE 7 trial tested HIPEC, the GETUG genitourinary group and the ESME real-world database, with Christophe Le Tourneau, Jean-Yves Blay and Thomas Bachelot among the people linked. OnCo connects it to colorectal and triple-negative breast cancer, to real-world evidence, and to ideas such as a publicly held library of investigational drugs for academic combination trials and one standing umbrella trial for all rare cancers in a country. Slow enrolment is the bottleneck it exists to solve. Its PRODIGE, UCBG and ESME programmes are listed in the notes.